Scarica l'app Stockscreener
7.38
1.34%
-0.10
Dopo l'orario di chiusura:
7.38
Precedente Chiudi:
$7.48
Aprire:
$7.75
Volume 24 ore:
121.12K
Relative Volume:
1.73
Capitalizzazione di mercato:
$422.09M
Reddito:
$154.57M
Utile/perdita netta:
$15.07M
Rapporto P/E:
27.33
EPS:
0.27
Flusso di cassa netto:
$10.92M
1 W Prestazione:
+5.28%
1M Prestazione:
-4.77%
6M Prestazione:
-7.17%
1 anno Prestazione:
+32.97%
Intervallo 1D:
$7.3585
$7.85
Intervallo di 1 settimana:
$7.002
$7.85
Portata 52W:
$5.17
$9.155
Kamada Ltd Stock (KMDA) Company Profile
Confronta KMDA con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
KMDA
Kamada Ltd
|
7.38 | 422.09M | 154.57M | 15.07M | 10.92M | 0.27 |
|
ZTS
Zoetis Inc
|
152.44 | 66.04B | 9.39B | 2.61B | 2.22B | 5.81 |
|
TAK
Takeda Pharmaceutical Co Adr
|
14.77 | 45.57B | 29.98B | 958.27M | 5.31B | 0.2964 |
|
HLN
Haleon Plc Adr
|
9.69 | 42.50B | 14.35B | 1.85B | 0 | 0.4023 |
|
TEVA
Teva Pharmaceutical Industries Ltd Adr
|
17.21 | 18.84B | 16.54B | -1.64B | 749.00M | -1.45 |
|
UTHR
United Therapeutics Corp
|
309.72 | 13.59B | 2.99B | 1.21B | 1.13B | 25.06 |
Kamada Ltd Stock (KMDA) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2025-03-21 | Iniziato | The Benchmark Company | Buy |
| 2024-07-03 | Iniziato | Stifel | Buy |
| 2018-02-02 | Iniziato | Chardan Capital Markets | Buy |
Kamada Ltd Borsa (KMDA) Ultime notizie
Kamada Q2 2025 Earnings Call Transcript - MarketBeat
Kamada Ltd Outpaces Expectations As FDA Nod Adds Fuel - Finimize
Kamada Ltd Outpaces Expectations With Strong Results And Upbeat Forecast - Finimize
Kamada Ltd reports results for the quarter ended June 30Earnings Summary - TradingView
Kamada: Q2 Earnings Snapshot - Connecticut Post
Kamada Ltd. Reports Strong Financial Results and FDA Approval in August 2025 - TipRanks
Kamada's Q2 Earnings and Strategic Growth Catalysts: A Deep Dive into a Biopharma Innovator's Scalable Model - AInvest
Will breakout in Kamada Ltd. lead to full recoveryMarket Volume Report & Weekly High Momentum Picks - Newser
Kamada Reports Strong Second Quarter and First Half 2025 - GlobeNewswire
Kamada Reports Q2 Earnings: EPS Beats Expectations, Revenue Misses - AInvest
Kamada Raises Full-Year Guidance as Plasma Therapy Sales Drive 35% Profit Growth - Stock Titan
How sentiment analysis helps forecast Kamada Ltd.July 2025 Review & Technical Analysis for Trade Confirmation - Newser
How hedge fund analytics apply to Kamada Ltd. stock2025 Geopolitical Influence & Safe Investment Capital Preservation Plans - Newser
Strategies to average down on Kamada Ltd.2025 Short Interest & Long-Term Safe Investment Plans - Newser
How to recover losses in Kamada Ltd. stockGold Moves & Daily Entry Point Alerts - Newser
Will Kamada Ltd. rebound enough to break even2025 Valuation Update & Fast Moving Stock Trade Plans - Newser
Can Kamada Ltd. deliver alphaMulti-Year Breakout Candidates - metrotimes.co.kr
What makes Kamada Ltd. stock price move sharplyWeekly Stock Market Strategy Summary - Newser
Kamada Ltd. shares fall 2.45% after-hours as Houston Center begins sales of Normal Source Plasma. - AInvest
Kamada Says Houston Center Cleared to Begin Sales of Normal Source Plasma - MarketScreener
Kamada’s Houston Plasma Center Gains FDA Approval - TipRanks
FDA approves Kamada’s Houston plasma collection center - Investing.com
Kamada Announces FDA Approval of its Plasma Collection Center in Houston, Texas - GlobeNewswire
Kamada Secures FDA Approval for $10M Revenue Plasma Center, Set to Be Largest Specialty Collection Site - Stock Titan
Intrinsic Value of Kamada Ltd. Stock: Is It Undervalued or OvervaluedFree Daily Volume Spike Trading Signals - Newser
Kamada (KMDA) Expected to Announce Earnings on Wednesday - Defense World
Screener Results Flag Kamada Ltd. as OversoldWealth Building Stock Market Ideas Based on Momentum - metal.it
What recovery options are there for Kamada Ltd.Free Pattern Detection for Entry Confirmation - Newser
Is Kamada Ltd. a top pick in the sectorCompounding Growth Ideas - kangso.co.kr
Exploring Analyst Estimates for Kamada (KMDA) Q2 Earnings, Beyond Revenue and EPS - Yahoo Finance
Full technical analysis of Kamada Ltd. stockProfitable Trading Blueprint with Entry Zones - Newser
Kamada Announces Q2 and H1 2025 Financial Results on August 13, 2025. - AInvest
Kamada to Announce Q2 and H1 2025 Financial Results on August 13, 2025 - AInvest
Kamada to Announce Second Quarter and First Half Ended June 30, 2025 Financial Results on August 13, 2025 - 富途牛牛
Is Kamada Ltd. still worth holding after the dipMomentum Prediction Based on AI Backtesting - Newser
Kamada Q2 Earnings: Rare Disease Biotech Giant Reveals Latest Financial Results Next Week - Stock Titan
Alpha-1 Antitrypsin Deficiency Pipeline Assessment Report - openPR.com
What is Kamada Ltd. company’s growth strategyAccelerated earnings growth - Jammu Links News
What are analysts’ price targets for Kamada Ltd. in the next 12 monthsTremendous return on equity - Jammu Links News
What is the dividend policy of Kamada Ltd. stockBuild a diversified portfolio for steady growth - Jammu Links News
What are the latest earnings results for Kamada Ltd.Free Trading Psychology Coaching - Jammu Links News
What markets is Kamada Ltd. expanding into Is TZOO stock a good long term investment optionExceptional ROI - Jammu Links News
What institutional investors are buying Kamada Ltd. stockGet daily expert analysis for smarter investing - Jammu Links News
Does Kamada Ltd. stock perform well during market downturnsUnlock powerful stock screening for profits - Jammu Links News
Is Kamada Ltd. a growth stock or a value stockHigh-octane gains - Jammu Links News
Why is Kamada Ltd. stock attracting strong analyst attentionMaximize profits with strategic stock selection - Jammu Links News
What markets is AVAH expanding into Is Kamada Ltd. stock a good long term investment optionBuild a diversified portfolio for sustainable growth - Jammu Links News
How does Kamada Ltd. compare to its industry peersFree Stock Market Trend Analysis - Jammu Links News
Is Kamada Ltd. a good long term investmentBuild a strong portfolio for long-term success - Jammu Links News
Kamada Ltd Azioni (KMDA) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
4.37%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):